Stockscreener 앱 받기
13.13
0.31%
0.04
시간 외 거래:
13.13
Celcuity Inc 주식(CELC)의 최신 뉴스
Celcuity Inc. (NASDAQ:CELC) Shares Purchased by Geode Capital Management LLC - Defense World
Celcuity Inc. (NASDAQ:CELC) Shares Acquired by Barclays PLC - Defense World
Analyzing Celcuity (NASDAQ:CELC) and CannLabs (OTCMKTS:CANL) - Defense World
Celcuity (NASDAQ:CELC) Trading Up 3.8%Here's Why - MarketBeat
State Street Corp Purchases 668,318 Shares of Celcuity Inc. (NASDAQ:CELC) - MarketBeat
How to Take Advantage of moves in (CELC) - Stock Traders Daily
Celcuity Inc. (NASDAQ:CELC) Receives $29.17 Consensus Target Price from Analysts - Defense World
Celcuity Inc. (NASDAQ:CELC) Given Average Rating of "Buy" by Analysts - MarketBeat
Wellington Management Group LLP Makes New Investment in Celcuity Inc. (NASDAQ:CELC) - MarketBeat
Mama's Creations Posts Weak Earnings, Joins EVgo, Red Cat Holdings And Other Big Stocks Moving Lower In Tuesday's Pre-Market SessionCelcuity (NASDAQ:CELC), Apellis Pharmaceuticals (NASDAQ:APLS) - Benzinga
Celcuity (CELC) Charges Forward with Promising Potential Cancer Treatments - TipRanks
Celcuity Inc. (NASDAQ:CELC) Short Interest Update - MarketBeat
Charles Schwab Investment Management Inc. Purchases 153,712 Shares of Celcuity Inc. (NASDAQ:CELC) - Defense World
(CELC) Investment Report - Stock Traders Daily
BNP Paribas Financial Markets Raises Holdings in Celcuity Inc. (NASDAQ:CELC) - MarketBeat
BNP Paribas Financial Markets Has $673,000 Stake in Celcuity Inc. (NASDAQ:CELC) - Defense World
Celcuity reports survival data for breast cancer drug - Investing.com
Celcuity Presents Overall Survival Data from Phase 1b Study Evaluating Gedatolisib in Combination with Palbociclib and Endocrine Therapy at the 2024 San Antonio Breast Cancer Symposium - The Manila Times
Celcuity Presents Overall Survival Data from Phase 1b Study - GlobeNewswire
Verition Fund Management LLC Reduces Holdings in Celcuity Inc. (NASDAQ:CELC) - MarketBeat
Braidwell LP Buys 367,663 Shares of Celcuity Inc. (NASDAQ:CELC) - MarketBeat
Celcuity Inc. (NASDAQ:CELC) Given Consensus Rating of "Buy" by Brokerages - MarketBeat
(CELC) Pivots Trading Plans and Risk Controls - Stock Traders Daily
Celcuity’s (CELC) “Buy” Rating Reiterated at Needham & Company LLC - Defense World
Celcuity’s (CELC) “Buy” Rating Reiterated at HC Wainwright - Defense World
Celcuity (NASDAQ:CELC) Receives "Buy" Rating from HC Wainwright - MarketBeat
Celcuity stock hits 52-week low at $12.14 amid market shifts - Investing.com
500: Something went wrong - Investing.com India
Earnings call: Celcuity reports Q3 2024 financials and clinical trial updates - Investing.com
Celcuity's (CELC) Buy Rating Reaffirmed at Needham & Company LLC - MarketBeat
Celcuity Inc. (NASDAQ:CELC) Q3 2024 Earnings Call Transcript - Insider Monkey
RA Capital Management, L.P. Acquires New Stake in Celcuity Inc - GuruFocus.com
Celcuity Inc (CELC) Q3 2024 Earnings Call Highlights: Clinical Milestones and Financial Challenges By GuruFocus - Investing.com Canada
COMMODORE CAPITAL LP's Strategic Acquisition of Celcuity Inc Sha - GuruFocus.com
Celcuity Inc. Reports Q3 Progress and Financials - TipRanks
Celcuity Inc. Reports Third Quarter Financial Results and Provides Corporate Update - The Manila Times
Celcuity CEO to Present at Stifel and Jefferies Healthcare Conferences This Month | CELC Stock News - StockTitan
Celcuity Inc. To Present at Upcoming Stifel and Jefferies Investor Conferences - GlobeNewswire
Long Term Trading Analysis for (CELC) - Stock Traders Daily
Celcuity (CELC) Scheduled to Post Earnings on Thursday - MarketBeat
Celcuity Inc. Schedules Release of Third Quarter 2024 Financial Results and Webcast/Conference Call - GlobeNewswire
Celcuity (CELC) to Report Q3 2024 Earnings: Oncology Pipeline Update Coming | CELC Stock News - StockTitan
Celcuity: Breast Cancer Drug Developer With Upcoming Catalysts (NASDAQ:CELC) - Seeking Alpha
TSX Venture Composite Index (JX) QuotePress Release - The Globe and Mail
Analysts Set Celcuity Inc. (NASDAQ:CELC) PT at $29.17 - MarketBeat
Celcuity Inc. (NASDAQ:CELC) Short Interest Up 9.3% in October - MarketBeat
Asml Holdings NY Reg ADR (ASML-Q) QuotePress Release - The Globe and Mail
Celcuity director Buller sells $5,687 in stock - Investing.com India
Celcuity director Buller sells $5,687 in stock By Investing.com - Investing.com Australia
0.67%
자본화:
|
볼륨(24시간):